Head-To-Head Comparison: Decision Diagnostics (OTCMKTS:DECN) & SpringBig (NASDAQ:SBIG)

SpringBig (NASDAQ:SBIG) and Decision Diagnostics (OTCMKTS:DECN) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Valuation and Earnings

This table compares SpringBig and Decision Diagnostics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpringBig	$28.37 million	0.13	-$10.23 million	($0.08)	-1.00
Decision Diagnostics	N/A	N/A	N/A	N/A	N/A

Decision Diagnostics has lower revenue, but higher earnings than SpringBig.

Volatility & Risk

SpringBig has a beta of 2.76, meaning that its stock price is 176% more volatile than the S&P 500. Comparatively, Decision Diagnostics has a beta of -1.77, meaning that its stock price is 277% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SpringBig and Decision Diagnostics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpringBig	0	0	1	0	3.00
Decision Diagnostics	0	0	0	0	0.00

SpringBig presently has a consensus target price of $1.00, indicating a potential upside of 1,150.00%. Given SpringBig’s stronger consensus rating and higher possible upside, equities research analysts clearly believe SpringBig is more favorable than Decision Diagnostics.

Institutional & Insider Ownership

30.9% of SpringBig shares are held by institutional investors. 41.0% of SpringBig shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares SpringBig and Decision Diagnostics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpringBig	-15.10%	N/A	-63.22%
Decision Diagnostics	N/A	N/A	N/A

Summary

SpringBig beats Decision Diagnostics on 7 of the 9 factors compared between the two stocks.

About SpringBig

SpringBig Holdings, Inc. develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada. Its platform offers customer loyalty and marketing automation solutions. The company was founded in 2016 and is headquartered in Boca Raton, Florida.

About Decision Diagnostics

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.